risperidone · Shandong Luye · NDA 212849
Rykindo
Earliest generic entry, as listed
10 Apr 2032
Blocked by patent: US 10098882, US 10406161, US 11110094, US 9446135, US 9532991.
Listed patents · 5 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10098882 | drug product, use U-3513 · sets the listed date | 10 Apr 2032 |
| US 10406161 | drug product, use U-3513 · sets the listed date | 10 Apr 2032 |
| US 11110094 | drug product · sets the listed date | 10 Apr 2032 |
| US 9446135 | drug product, use U-3513 · sets the listed date | 10 Apr 2032 |
| US 9532991 | drug product, use U-3513 · sets the listed date | 10 Apr 2032 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 212849 · 001 · RLD · discontinued | for suspension, extended release, intramuscular | 12.5MG | 10 Apr 2032 |
| 212849 · 002 · RLD | for suspension, extended release, intramuscular | 25MG | 10 Apr 2032 |
| 212849 · 003 · RLD · discontinued | for suspension, extended release, intramuscular | 37.5MG | 10 Apr 2032 |
| 212849 · 004 · RLD · discontinued | for suspension, extended release, intramuscular | 50MG | 10 Apr 2032 |